Neil McHughConsultant Rheumatologist, Royal National Hospital for Rheumatic Diseases (RNHRD), Bath, UK; Professor of Pharmacoepidemiology, University of Bath, UK
Professor Neil McHugh graduated from Otago University Medical School, Dunedin, New Zealand, and completed physician training before specialising in the subspecialty of rheumatology. He has undertaken research fellowships at the Walter and Eliza Hall in Melbourne, Australia (1985), Yale University Medical School, USA (1990–1991), and the National Heart and Lung Institute, UK (2002–2004).
Professor McHugh has been a Consultant Rheumatologist at the RNHRD since 1991, and Professor of Pharmacoepidemiology at the University of Bath since 2013. His current interests include the serology of idiopathic inflammatory myositis, scleroderma, lupus and juvenile idiopathic arthritis. His laboratory group offers specialist autoimmune serology at the University of Bath, leads on a major European study of adult and juvenile idiopathic myositis, and has identified a number of novel diagnostic autoantibody biomarkers.
Professor McHugh also leads a programme of work related to psoriatic disease, including a National Institute for Health Research programme grant related to the early detection and optimisation of outcome measures in psoriatic arthritis. He has led on successive British Society for Rheumatology guidelines for biologics in psoriatic arthritis, and has been involved in National Institute for Health and Care Excellence and other international guidelines for psoriatic disease.
view this profile
Type 1 diabetes is an autoimmune condition that permanently destroys beta cells in the pancreas and is most common in children, but can be diagnosed at any age.